Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity - La Manna, Federico; De Menna, Marta; Patel, Nikhil; Karkampouna, Sofia; De Filippo, Maria Rosaria; Klima, Irena; Kloen, Peter; Beimers, Lijkele; Thalmann, George N.; Pelger, Rob C. M.; Jacinto, Estela; Kruithof-de Julio, Marianna (Frontiers in Oncology, 2021)